Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernadette Porter

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Lancet. Neurology|June 20, 2006
Home versus outpatient administration of intravenous steroids for multiple-sclerosis relapses: a randomised controlled trialJeremy Chataway, Bernadette Porter, Afsane Riazi, et al.
Multiple Sclerosis and Related Disorders|August 9, 2020
The prevention and management of hospital admissions for urinary tract infection in patients with multiple sclerosisVivien Li, Noreen Barker, Carmel Curtis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 20, 2016
Urinary tract infections in multiple sclerosisVéronique Phé, Mahreen Pakzad, Carmel Curtis, et al.
Neurourology and Urodynamics|November 5, 2016
Open label feasibility study evaluating D-mannose combined with home-based monitoring of suspected urinary tract infections in patients with multiple sclerosisVéronique Phé, Mahreen Pakzad, Collette Haslam, et al.
Plos One|March 19, 2015
A predictive model for corticosteroid response in individual patients with MS relapsesMartin Rakusa, Stefan J Cano, Bernadette Porter, et al.
Journal of the Neurological Sciences|October 17, 2019
Screening for urinary tract colonisation prior to corticosteroid administration in acute multiple sclerosis relapses: Validation of an updated algorithmFergus O'Herlihy, Nevin A John, Vivien Li, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Lancet. Neurology|June 20, 2006
Home versus outpatient administration of intravenous steroids for multiple-sclerosis relapses: a randomised controlled trialJeremy Chataway, Bernadette Porter, Afsane Riazi, et al.
Multiple Sclerosis and Related Disorders|August 9, 2020
The prevention and management of hospital admissions for urinary tract infection in patients with multiple sclerosisVivien Li, Noreen Barker, Carmel Curtis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 20, 2016
Urinary tract infections in multiple sclerosisVéronique Phé, Mahreen Pakzad, Carmel Curtis, et al.
Neurourology and Urodynamics|November 5, 2016
Open label feasibility study evaluating D-mannose combined with home-based monitoring of suspected urinary tract infections in patients with multiple sclerosisVéronique Phé, Mahreen Pakzad, Collette Haslam, et al.
Plos One|March 19, 2015
A predictive model for corticosteroid response in individual patients with MS relapsesMartin Rakusa, Stefan J Cano, Bernadette Porter, et al.
Journal of the Neurological Sciences|October 17, 2019
Screening for urinary tract colonisation prior to corticosteroid administration in acute multiple sclerosis relapses: Validation of an updated algorithmFergus O'Herlihy, Nevin A John, Vivien Li, et al.
Pageof 2